华润双鹤(600062.SH)：奥卡西平片获得药品注册证书

Core Points - China Resources Double Crane (600062.SH) announced that its subsidiary Hunan Xiangzhong Pharmaceutical Co., Ltd. has received the drug registration certificate for Oxcarbazepine Tablets from the National Medical Products Administration [1] Company Summary - The drug Oxcarbazepine Tablets is indicated for the treatment of primary generalized tonic-clonic seizures and partial seizures in adults and children aged 5 years and older, with or without secondary generalized seizures [1]